164 related articles for article (PubMed ID: 16095048)
1. Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.
Kärkkäinen J; Forsström T; Tornaeus J; Wähälä K; Kiuru P; Honkanen A; Stenman UH; Turpeinen U; Hesso A
Scand J Clin Lab Invest; 2005; 65(3):189-99. PubMed ID: 16095048
[TBL] [Abstract][Full Text] [Related]
2. Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS.
Forsström T; Tuominen J; Karkkäinen J
Scand J Clin Lab Invest; 2001; 61(7):547-56. PubMed ID: 11763413
[TBL] [Abstract][Full Text] [Related]
3. A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
Barker SA; McIlhenny EH; Strassman R
Drug Test Anal; 2012; 4(7-8):617-35. PubMed ID: 22371425
[TBL] [Abstract][Full Text] [Related]
4. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
5. Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders.
Takeda N; Ikeda R; Ohba K; Kondo M
Neuroreport; 1995 Nov; 6(17):2378-80. PubMed ID: 8747157
[TBL] [Abstract][Full Text] [Related]
6. Comparing the Detection of Endogenous Psychedelics in Individuals With and Without Alleged Mediumistic Experiences.
Vinhosa Bastos MA; Haidamus de Oliveira Bastos PR; Dos Santos ML; Iandoli D; Boschi Portella R; Lucchetti G
Explore (NY); 2018 Nov; 14(6):448-452. PubMed ID: 30241696
[TBL] [Abstract][Full Text] [Related]
7. Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats.
Glynos NG; Carter L; Lee SJ; Kim Y; Kennedy RT; Mashour GA; Wang MM; Borjigin J
Sci Rep; 2023 Jan; 13(1):280. PubMed ID: 36609666
[TBL] [Abstract][Full Text] [Related]
8. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
Vitale AA; Pomilio AB; Cañellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
[TBL] [Abstract][Full Text] [Related]
9. Concise synthesis of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine starting with bufotenine from Brazilian Anadenanthera ssp.
Moreira LA; Murta MM; Gatto CC; Fagg CW; dos Santos ML
Nat Prod Commun; 2015 Apr; 10(4):581-4. PubMed ID: 25973481
[TBL] [Abstract][Full Text] [Related]
10. Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine.
Räisänen M; Kärkkäinen J
J Chromatogr; 1979 Apr; 162(4):579-84. PubMed ID: 118980
[No Abstract] [Full Text] [Related]
11. Determination of N,N-dimethylindolealkylamines in plasma, blood and urine extracts by radioimmunoassay and high pressure liquid chromatography.
Riceberg LJ; Vunakis HV
J Pharmacol Exp Ther; 1978 Jul; 206(1):158-66. PubMed ID: 275476
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.
Riba J; McIlhenny EH; Bouso JC; Barker SA
Drug Test Anal; 2015 May; 7(5):401-6. PubMed ID: 25069786
[TBL] [Abstract][Full Text] [Related]
13. Bufotenine: toward an understanding of possible psychoactive mechanisms.
McBride MC
J Psychoactive Drugs; 2000; 32(3):321-31. PubMed ID: 11061684
[TBL] [Abstract][Full Text] [Related]
14. Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.
Aghajanian GK; Hailgler HJ
Psychopharmacol Commun; 1975; 1(6):619-29. PubMed ID: 1063421
[TBL] [Abstract][Full Text] [Related]
15. Interaction of psychedelic tryptamine derivatives with a lipid bilayer.
Zohairi F; Khandelia H; Hakami Zanjani AA
Chem Phys Lipids; 2023 Mar; 251():105279. PubMed ID: 36627076
[TBL] [Abstract][Full Text] [Related]
16. Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.
Chu UB; Vorperian SK; Satyshur K; Eickstaedt K; Cozzi NV; Mavlyutov T; Hajipour AR; Ruoho AE
Biochemistry; 2014 May; 53(18):2956-65. PubMed ID: 24730580
[TBL] [Abstract][Full Text] [Related]
17. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
Barker SA; Littlefield-Chabaud MA; David C
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
[TBL] [Abstract][Full Text] [Related]
18. Bufotenine esters.
Glennon RA; Gessner PK; Godse DD; Kline BJ
J Med Chem; 1979 Nov; 22(11):1414-6. PubMed ID: 533890
[TBL] [Abstract][Full Text] [Related]
19. A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
Frecska E; Szabo A; Winkelman MJ; Luna LE; McKenna DJ
J Neural Transm (Vienna); 2013 Sep; 120(9):1295-303. PubMed ID: 23619992
[TBL] [Abstract][Full Text] [Related]
20. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
Smith RL; Canton H; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
